{
  "event_id": "6bb116d8d45e",
  "ticker": "AMGN",
  "company_name": "Amgen",
  "drug_name": "TAVNEOS",
  "result": "approved",
  "pdufa_date": "2022-07-06",
  "approval_type": {
    "status": "found",
    "value": "nda",
    "source": "websearch:ADVOCATE trial, NEJM 2021",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.098784",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "ANCA-associated vasculitis",
    "source": "websearch:ADVOCATE trial, NEJM 2021",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.098785",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "avacopan",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Immunology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.443725",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "C5aR inhibitor",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.006439",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:ADVOCATE trial, NEJM 2021",
    "confidence": 0.9,
    "evidence": [
      "ADVOCATE trial, NEJM 2021"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.098771",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "<0.001",
    "source": "websearch:ADVOCATE trial, NEJM 2021",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.098777",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "Week 52 sustained remission: 65.7% vs 54.9% (12.5pp diff)",
    "source": "websearch:ADVOCATE trial, NEJM 2021",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.098780",
    "error": null
  },
  "has_prior_crl": {
    "status": "found",
    "value": false,
    "source": "derived_from_first_submission",
    "confidence": 0.95,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "p_value_numeric": 0.001,
  "nct_ids": [
    "NCT02994927"
  ],
  "phase3_study_names": [
    "A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine"
  ],
  "prior_crl_reason": null,
  "enrollment": {
    "count": 331,
    "type": "ACTUAL",
    "nct_id": "NCT02994927",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:24:40.931906"
  },
  "fda_designations": {
    "breakthrough_therapy": false,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "date": null,
    "outcome": null,
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": false,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=PARALLEL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:33.208130",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['AUSTRALIA', 'BELGIUM', 'NETHERLANDS', 'SWEDEN', 'CZECHIA']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:33.208189",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": false,
    "status": "found",
    "source": "approval_type_nda",
    "confidence": 0.9,
    "tier": 2,
    "evidence": [
      "approval_type=nda"
    ],
    "searched_sources": [
      "approval_type_nda"
    ],
    "last_searched": "2026-01-10T13:11:17.303949",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": "2014-01-27",
    "status": "found",
    "source": "fda.gov",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [
      "Thousand Oaks CA facility - drug/device combo violations (Prolia, Enbrel prefilled syringes)"
    ],
    "searched_sources": [
      "fda.gov"
    ],
    "last_searched": "2026-01-11T04:05:14.877550",
    "error": null,
    "note": null
  },
  "fda_483_date": {
    "value": "2023-05-01",
    "status": "found",
    "source": "redica.com",
    "confidence": 0.8,
    "tier": 3,
    "evidence": [
      "Facility: Thousand Oaks, CA",
      "Outcome: N/A"
    ],
    "searched_sources": [
      "redica.com"
    ],
    "last_searched": "2026-01-11T05:25:26.295576",
    "error": null,
    "facility": "Thousand Oaks, CA"
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:30:43.700531",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:30:44.725659",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -1284,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.182062",
  "original_case_id": "cce0f5c97f51",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:39:24.916404",
  "enriched_at": "2026-01-11T17:32:50.101773",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.006460",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": true,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [
      "Tavneos (avacopan) FDA Approval History - Drugs.com Experts share early details prescribing avacopan",
      "What Milestones Led to Tavneos FDA Approval in Record Time"
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:32:50.101762"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_found",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:32:50.101770"
  },
  "breakthrough_therapy": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [
      "ChemoCentryx scores first FDA approval in 24-year history ... What Milestones Led to Tavneos FDA App"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:28:09.038359",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "What Milestones Led to Tavneos FDA Approval in Record Time"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:28:15.058268",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:28:21.532692",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "FDA approves add-on drug for adults with rare form of blood ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:28:10.428626",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:28:28.173158",
    "search_status": "CONFIRMED_NONE"
  }
}